PHARMA MARINE AS, headquartered in Norway, is a prominent player in the marine biotechnology industry, specialising in the development of innovative pharmaceutical products derived from marine organisms. Founded in 2007, the company has made significant strides in harnessing the unique properties of marine life to create effective treatments, particularly in oncology and infectious diseases. With a strong operational presence in Europe and beyond, PHARMA MARINE AS is recognised for its commitment to research and development, leading to the creation of unique bioactive compounds. Their core offerings include marine-derived pharmaceuticals that stand out for their efficacy and safety profiles. The company has achieved notable milestones, positioning itself as a leader in the marine biotechnology sector, dedicated to advancing healthcare through the exploration of the ocean's untapped resources.
How does PHARMA MARINE AS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
PHARMA MARINE AS's score of 6 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
PHARMA MARINE AS, headquartered in Norway, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, the company may still be engaged in industry-standard practices aimed at reducing environmental impact, although details on such initiatives are not provided. As the industry increasingly focuses on sustainability, it is essential for companies like PHARMA MARINE AS to establish clear climate commitments and measurable targets to align with global efforts in combating climate change.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PHARMA MARINE AS is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.